Review Article

Pleiotropic Effects of Eugenol: The Good, the Bad, and the Unknown

Table 2

Overview of the anti-inflammatory, antioxidant, and anticarcinogenic effects of eugenol.

Eugenol propertiesParameters/tumor typeBiological effectsRef.

Anti-inflammatoryHistological quantification of liver inflammatory foci/microscopic fieldDecrease of the liver inflammatory cell infiltration[90]

Anti-inflammatoryCytokine levelsDecrease of the TNF-α and IL-6 level in the culture supernatant of RA-PBMCs[91]

Anti-inflammatoryMouse skin expression of COX-2 cytokine levelsDecrease of skin COX-2 expression and serum TNF-α, IL-6, and PGE2 level in TPA-treated mice[95]

Anti-inflammatoryLeukocyte migrationDecrease of the number and adherence of leukocytes[86]

Anti-inflammatoryCytokine levelsInhibition of lung infiltration with eosinophils decrease of IL-4 and IL-5 levels[89]

Anti-inflammatoryCytokine levelsInhibition of TNF-α, IL-1β, and IL-6 release[88]

Anti-inflammatoryInflammatory cells cytokine level NF-κB activationInhibition of lung infiltration with neutrophils/macrophages; reduction of TNF-α release and of NF-κB activation[76]

Anti-inflammatoryInflammation-related gene expression (NF-κB, IL-1β, and TNF-α)Inhibition of NF-κB and TNF-α gene expression[61]

AntioxidantAntioxidant enzyme (SOD and CAT) activityIncrease of serum SOD and CAT activity[90]

AntioxidantIntracellular ROS production and reduced glutathione level antioxidant enzyme (SOD, CAT, and GPx) activityDecrease of ROS generation and increase of reduced glutathione level in RA-PBMC increase of SOD, CAT, and GPx activity in RA-PBMC culture[91]

AntioxidantCutaneous glutathione level and glutathione reductase, CAT, and GPx activityIncrease of cutaneous glutathione level and glutathione reductase, CAT, and GPx activity in TPA-treated mice[95]

AnticarcinogenicMCF-7 human breast cancer cellsInhibition of human breast cancer cell proliferation[102]

AnticarcinogenicMouse skin cancerReduction in tumor size and incidence[95]

AnticarcinogenicMouse skin cancerRestriction of skin carcinogenesis at the dysplastic stage[96]

AnticarcinogenicRat gastric cancerInhibition of gastric carcinoma development through NF-κB suppression[99]
Apoptosis stimulation through modulation of Bcl-2 proteins, Apaf-1, caspases, and cytochrome c inhibition of invasion and angiogenesis by MMP activity and VEGF and TIMP-2 expression modulation[98]

AnticarcinogenicHSC-2 human oral squamous cell carcinoma cell lineNonapoptotic cell death through oxidative stress and reduction of ATP utilization[108]

AnticarcinogenicHuman melanoma cells B16 xenograft mouse modelTumor size reduction and delay in tumor growth; prevention of metastasis[97]

AnticarcinogenicHuman breast cancer cellsProliferation inhibition and apoptosis stimulation through down-regulation of survivin and the E2F1 transcription factor[103]

AnticarcinogenicA549 human lung adenocarcinoma cellsInhibition of cell proliferation, migration, and invasion through modulation of MMP activity and the PI3K/Akt pathway[100]

AnticarcinogenicHCT-15 and HT-29 human colorectal adenocarcinoma cellsApoptosis stimulation through the reduction of ΔΨm with oxidative stress and DNA fragmentation[106]

AnticarcinogenicHL-60 human promyelocytic leukemia cellsApoptosis stimulation through oxidative stress, MPT, and cytochrome c release, reduction of Bcl-2 level and DNA fragmentation[107]

AnticarcinogenicHuman KB oral squamous carcinoma cells and DU-145 androgen-insensitive prostate cancer cellsCell growth inhibition and apoptosis stimulation[104]

AnticarcinogenicMDA-MB-231, MCF-7 (breast cancer lines), SIHA (cervix cancer lines), SK-Mel-28, and A2058 (melanoma lines)Apoptosis stimulation through cell cycle deregulation and DNA damage, ROS overproduction, disruption of the cytoplasmic membrane, mitochondrial failure, PCNA downregulation[105]

RA-PBMCs: PBMCs isolated from rheumatoid arthritis patients; TPA: 12-O-tetradecanoylphorbol-13-acetate; MAPK: mitogen-activated protein kinases; SOD: superoxide dismutase; CAT: catalase; GPx: glutathione peroxidase; PARP: polyadenosinediphosphate-ribose polymerase; MPT: mitochondrial permeability transition; PCNA: proliferation cell nuclear antigen; ΔΨm: mitochondrial membrane potential.